Skip to content
This GLP
Updated September 2026Forty-eight weeks in an asterisk

Woodwork review

The advertised figure carries an asterisk, and the asterisk says forty-eight weeks.

The verdict

Woodwork advertises compounded semaglutide from $127 a month, read August 2026, with an asterisk stating the price applies to a 48-week plan. Tirzepatide is $199 under the same condition.

Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Category
GLP-1 telehealth
Molecule
Semaglutide · Tirzepatide
Form
Injection
From
$127/mo
Prescription
Required
Compounded
Yes — not FDA-approved

Woodwork sells semaglutide as injections or oral tablets and tirzepatide by injection. Both advertised figures belong to a near-year commitment.

  1. Who writes the prescription, and what do they see?

    A prescription precedes shipping. The pages name products and terms. The clinician is not described.

    The condition is disclosed and it is disclosed in an asterisk, which is the smallest place a forty-eight week commitment can be put. Nothing is hidden and nothing is prominent either.

  2. What happens when the dose goes up?

    Nothing is published about dose on either line. The from wording leaves a floor as well, so two variables sit behind a figure that already requires most of a year.

  3. What the price includes

    Forty-eight weeks at $127 is about $1,406 committed, and that is the only path to the advertised rate. No shorter term is published, so a reader wanting three months cannot price it. Tirzepatide at $199 across the same term is about $2,203.

  4. What it claims, and what it cites

    Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.

Where it holds up, and where it does not

  • Strength: The 48-week condition is disclosed
  • Strength: An oral option exists on semaglutide
  • Strength: Both molecules carry a figure
  • Limitation: The condition sits in an asterisk
  • Limitation: No shorter term is published at all
  • Limitation: Both figures also use from wording
  • Limitation: No state coverage list is recorded

What the evidence says about this kind of treatment

The assessment above is about Woodwork. These are about the drugs it sells, and they are traced to the primary literature.

Right for
A reader ready to commit forty-eight weeks who reads asterisks.
Wrong for
A reader wanting a shorter term, which is not priced.

How Woodwork compares

SellerWho it suitsGo
YourEraReaders committing six months who have read which figure belongs to which planSee YourEra
VitaStirReaders who will price the rung they expect to reach rather than the entry oneSee VitaStir
YourHealthRxReaders in any jurisdiction wanting a flat rate with little to decideSee YourHealthRx
Compare all providers side by side →

More GLP-1 telehealth sellers reviews: Breeze MedsCare Bare RxCoreAge RxStrut HealthSynergy RxActin

Sponsored alternative

Synergy Rx

A reader who wants the oral and injectable rates for both molecules stated up front rather than after an intake form.

Check Synergy Rx availability →

Frequently asked

What does the asterisk say?
That the price applies to the 48-week semaglutide injection plan. It is the condition on the advertised figure.
Is a shorter plan available?
None is published, so a reader wanting three months cannot price it from the site.
What does the commitment total?
About $1,406 for semaglutide across 48 weeks, or about $2,203 for tirzepatide.
Is Woodwork expensive compared with other GLP-1 telehealth sellers?
Woodwork publishes a starting figure of $127/mo. Across the 169 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $76 to $369 with a median of $179, which puts Woodwork below the median, toward the cheaper end. The other 11 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.
Dana SullivanEvidence reviewer · Reviewed and last verified September 2026

How this was assessed. The four questions above are answered from Woodwork’s own publicly-stated model, against the published editorial methodology. No ratings are fabricated and no first-hand outcomes are claimed. A partnership never changes the assessment — see how we make money.